FY2024 EPS Estimates for Taysha Gene Therapies, Inc Cut by Analyst (NASDAQ:TSHA) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Taysha Gene Therapies (NASDAQ:TSHA – Free Report) had its target price boosted by Cantor Fitzgerald from $6.00 to $7.00 in a research report sent to investors on Wednesday morning, Benzinga reports. The firm currently has an overweight rating on the stock. Several other research firms also recently issued reports on TSHA. Needham & Company LLC […]
Taysha Gene Therapies, Inc (NASDAQ:TSHA) Receives $7 91 Consensus PT from Analysts themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Get Free Report) was the target of a large growth in short interest in September. As of September 15th, there was short interest totalling 9,930,000 shares, a growth of 34.9% from the August 31st total of 7,360,000 shares. Based on an average daily volume of 4,830,000 shares, the days-to-cover […]
Needham & Company LLC reiterated their buy rating on shares of Taysha Gene Therapies (NASDAQ:TSHA – Free Report) in a research report sent to investors on Wednesday morning, Benzinga reports. They currently have a $5.00 target price on the stock. Several other research firms have also commented on TSHA. Robert W. Baird boosted their price […]